Stay updated on SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial

Sign up to get notified when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.2 instead of v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:54:50.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The new screenshot shows an updated revision label: v3.4.1 replaces v3.4.0. No substantive changes to study details, eligibility criteria, outcomes, or navigation were observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:55:06.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a glossary toggle and updated metadata labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) while removing older labels (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4). These changes do not affect the study content, eligibility, endpoints, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:39:19.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    An added Revision: v3.3.4 and removal of Revision: v3.3.3 are shown. These are internal version updates and do not modify the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-01-14T04:20:08.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section with Maryland and Texas sites and UT Southwestern Medical Center as sponsor, and updated the revision to v3.3.3. The update also removes the HHS Vulnerability Disclosure link and the prior Maryland, Texas, and UT Southwestern Medical Center entries (v3.3.2).
    Difference
    0.4%
    Check dated 2025-12-23T22:19:27.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    A new revision note, v3.3.2, was added and the older v3.2.0 revision was removed. There are no changes to the study content or user-facing information.
    Difference
    0.1%
    Check dated 2025-11-25T11:21:33.000Z thumbnail image

Stay in the know with updates to SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SBRT+Nivolumab/Ipilimumab in RCC Clinical Trial page.